Loading...
XETR
HNL
Market cap59mUSD
May 05, Last price  
8.54EUR
1D
0.93%
1Q
-0.69%
Jan 2017
-69.43%
IPO
-6.09%
Name

Dr Hoenle AG

Chart & Performance

D1W1MN
No data to show
P/E
—
P/S
0.52
EPS
—
Div Yield, %
—
Shrs. gr., 5y
1.92%
Rev. gr., 5y
-1.73%
Revenues
99m
-7.16%
22,822,000026,246,00048,744,00044,985,00054,624,00067,878,00072,092,00077,273,00082,090,00092,173,00093,415,000101,926,000126,492,000107,747,00093,876,000115,170,000126,529,000106,342,00098,729,000
Net income
-13m
L+20.68%
2,708,00003,167,0004,569,000-4,083,0004,806,0006,879,0005,848,0006,620,0006,256,00010,128,0008,278,00010,427,00021,738,00012,477,0005,678,000-4,860,000-13,198,000-11,006,000-13,282,000
CFO
6m
+75.95%
1,788,0004,326,0005,275,0001,886,000-3,096,0004,644,00010,293,0003,624,0005,363,0007,492,0009,159,0008,356,0006,579,00024,216,00016,924,0007,234,0001,130,000-7,406,0003,143,0005,530,000
Dividend
Mar 25, 20220.2 EUR/sh
Earnings
May 06, 2025

Profile

Dr. Hönle AG supplies industrial UV technologies and systems in Germany and internationally. The company operates through three segments: Adhesives, Equipment & Systems, and Glass & Lamps. The Adhesives segment provides industrial adhesives for applications, such as consumer electronics, medical technology, optics and opto electronics, automotive, and glass processing. The Equipment & Systems segment engages in the drying of inks and coatings, curing of adhesives and plastics, disinfecting surfaces, and solar simulation. The Glass & Lamps segment offers quartz glass tubing and rods for the lamp, automotive, semiconductor, and fibre cable industries, as well as lamps for water disinfection, and the drying of coatings and adhesives. The company was founded in 1976 and is headquartered in Munich, Germany.
URL
https://www.hoenle.de/
IPO date
Feb 25, 2008
Employees
581
Domiciled in
DE
Incorporated in
DE

Valuation

Title
EUR in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑092023‑092022‑092021‑092020‑092019‑092018‑092017‑092016‑092015‑09
Income
Revenues
98,729
-7.16%
106,342
-15.95%
126,529
9.86%
Cost of revenue
47,440
67,606
80,823
Unusual Expense (Income)
NOPBT
51,289
38,736
45,706
NOPBT Margin
51.95%
36.43%
36.12%
Operating Taxes
766
273
1,652
Tax Rate
1.49%
0.70%
3.61%
NOPAT
50,523
38,463
44,054
Net income
(13,282)
20.68%
(11,006)
-16.61%
(13,198)
171.56%
Dividends
(123)
(123)
(1,212)
Dividend yield
0.17%
0.11%
1.38%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
14,335
13,748
27,782
Long-term debt
41,397
45,753
34,953
Deferred revenue
60
63
115
Other long-term liabilities
4,545
3,391
4,341
Net debt
48,224
43,588
48,835
Cash flow
Cash from operating activities
5,530
3,143
(7,406)
CAPEX
(2,094)
(2,934)
(4,309)
Cash from investing activities
(2,372)
2,651
(1,692)
Cash from financing activities
(4,904)
(3,417)
3,731
FCF
57,767
51,589
49,358
Balance
Cash
7,508
9,317
7,131
Long term investments
6,596
6,769
Excess cash
2,572
10,596
7,574
Stockholders' equity
37,716
54,163
71,879
Invested Capital
134,961
145,886
161,337
ROIC
35.98%
25.04%
26.75%
ROCE
37.08%
24.57%
26.90%
EV
Common stock shares outstanding
6,062
6,062
6,062
Price
11.70
-34.82%
17.95
23.96%
14.48
-64.55%
Market cap
70,924
-34.82%
108,810
23.96%
87,776
-64.55%
EV
119,414
152,712
136,968
EBITDA
64,518
48,680
60,179
EV/EBITDA
1.85
3.14
2.28
Interest
2,074
1,816
1,528
Interest/NOPBT
4.04%
4.69%
3.34%